
Hearing implant developer and manufacturer Cochlear is sounding out the market, launching its latest implant and cutting earnings guidance on the same day.
Weaker-than-expected sales forced the health technology company to trim net profit expectations to between $390 to $400 million, down from $410 million to $430 million, but still higher than FY24's $387 million result.